NO973656D0 - Pharmaceutical composition for parenteral use containing an indole carboxylic acid - Google Patents

Pharmaceutical composition for parenteral use containing an indole carboxylic acid

Info

Publication number
NO973656D0
NO973656D0 NO973656A NO973656A NO973656D0 NO 973656 D0 NO973656 D0 NO 973656D0 NO 973656 A NO973656 A NO 973656A NO 973656 A NO973656 A NO 973656A NO 973656 D0 NO973656 D0 NO 973656D0
Authority
NO
Norway
Prior art keywords
carboxylic acid
pharmaceutical composition
parenteral use
use containing
indole carboxylic
Prior art date
Application number
NO973656A
Other languages
Norwegian (no)
Other versions
NO973656L (en
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of NO973656D0 publication Critical patent/NO973656D0/en
Publication of NO973656L publication Critical patent/NO973656L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO973656A 1995-02-11 1997-08-08 Pharmaceutical composition for parenteral use containing an indole carboxylic acid NO973656L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition
PCT/EP1996/000515 WO1996024376A1 (en) 1995-02-11 1996-02-08 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid

Publications (2)

Publication Number Publication Date
NO973656D0 true NO973656D0 (en) 1997-08-08
NO973656L NO973656L (en) 1997-10-08

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973656A NO973656L (en) 1995-02-11 1997-08-08 Pharmaceutical composition for parenteral use containing an indole carboxylic acid

Country Status (18)

Country Link
US (2) US5886018A (en)
EP (1) EP0809514A1 (en)
JP (1) JPH10513464A (en)
KR (1) KR19980702109A (en)
AU (1) AU707220B2 (en)
BR (1) BR9607433A (en)
CA (1) CA2212041A1 (en)
CZ (1) CZ252897A3 (en)
EA (1) EA000211B1 (en)
FI (1) FI973280A0 (en)
GB (1) GB9502695D0 (en)
HU (1) HUP9702448A2 (en)
IL (1) IL117098A0 (en)
NO (1) NO973656L (en)
NZ (1) NZ300937A (en)
PL (1) PL321734A1 (en)
WO (1) WO1996024376A1 (en)
ZA (1) ZA961051B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
PL1848419T3 (en) 2005-02-01 2012-12-31 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenac and its pharmaceutically acceptable salts
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
WO2018229744A1 (en) 2017-06-12 2018-12-20 Glytech Llc. Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93943A (en) * 1989-05-05 1991-02-08 Searle & Co PROCESS FOR THE PREPARATION OF COMPOUNDS CONTAINING INDOLE-2-CARBOXYLATE COMPOUNDS FOR TREATMENT OF CNS DISTURBACTIONS
WO1992001670A1 (en) * 1990-07-16 1992-02-06 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
IL117098A0 (en) 1996-06-18
CA2212041A1 (en) 1996-08-15
GB9502695D0 (en) 1995-03-29
US5886018A (en) 1999-03-23
AU4622896A (en) 1996-08-27
WO1996024376A1 (en) 1996-08-15
EA000211B1 (en) 1998-12-24
CZ252897A3 (en) 1998-03-18
NZ300937A (en) 1999-02-25
EP0809514A1 (en) 1997-12-03
FI973280A (en) 1997-08-08
EA199700095A1 (en) 1998-02-26
FI973280A0 (en) 1997-08-08
NO973656L (en) 1997-10-08
PL321734A1 (en) 1997-12-22
JPH10513464A (en) 1998-12-22
AU707220B2 (en) 1999-07-08
ZA961051B (en) 1996-09-11
MX9706044A (en) 1998-06-28
KR19980702109A (en) 1998-07-15
US6020359A (en) 2000-02-01
HUP9702448A2 (en) 1999-10-28
BR9607433A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
FI944800A (en) Indole-2-carboxylic acid derivatives
ATE211131T1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES
FI973518A (en) Pharmaceutical composition for piperidinoalkanol compounds
DE69634416D1 (en) QUINOLINE DERIVATIVES
NO961475D0 (en) Indole derivatives
NO308236B1 (en) Pharmaceutical composition containing indole derivatives
EE9900140A (en) Pharmaceutical microspheres containing valproic acid for oral administration
NO973656D0 (en) Pharmaceutical composition for parenteral use containing an indole carboxylic acid
FI960634A (en) New quinolone carboxylic acid derivatives
NO975296L (en) Process for the preparation of carboxylic acid derivatives
FI953361A (en) Process for the preparation of substituted indolone derivatives
BR9610139A (en) Carboxylic acid derivative
DK0725061T3 (en) Substituted indole derivatives
HU9602637D0 (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives
DE69822338D1 (en) POLYISOBUTEN SUBSTITUTED succinic acid imides
DK0876367T3 (en) Trans apovincamic acid ester derivatives as drugs
UA1040S (en) GLASS BOTTLE FOR ACETIC ACID
DE59605373D1 (en) Substituted indole derivatives
SI0876367T1 (en) Trans apovincaminic acid ester derivatives as drugs
KR970020156U (en) Simple turntable for TV
SE9503923D0 (en) New amino acid derivatives
SE9502503D0 (en) New amino acid derivatives
SE9502504D0 (en) New amino acid derivatives
SE9502505D0 (en) New amino acid derivatives
SE9504349D0 (en) New amino acid derivatives